Acute and maintenance effects of non-pharmacologic interventions for antipsychotic associated weight gain and metabolic abnormalities: a meta-analytic comparison of randomized controlled trials.

Caemmerer, Jacqueline, Correll, Christoph U., Maayan, Lawrence·2012·Schizophrenia Research

Cited by (182)

Items 101–182 of 182

  1. Lifestyle intervention based on exercise and behavioural counselling and its effect on physical and psychological health in outpatients with schizophrenia spectrum disorders. An exploratory, pragmatic randomized clinical trial
    Blanca Fernández-Abascal, Marta Suárez‐Pinilla, Carlos Cobo-Corrales, Benedicto Crespo‐Facorro, Paula Suárez‐Pinilla · 2023 · Schizophrenia Research
  2. A 12-Week Evidence-Based Education Project to Reduce Cardiovascular and Metabolic Risk in Adults With Serious Mental Illness in the Integrated Care Setting
    A. Fenton, P. Sharps, Karan Kverno, J. Rachbeisel, Marsha Gorth · 2020 · Journal of the American Psychiatric Nurses Association
  3. Factors to consider during the implementation of nutrition and physical activity trials for people with psychotic illness into an Australian community setting
    Doreen Mucheru, Samantha Ashby, Mary‐Claire Hanlon, Mark McEvoy, Lesley K. MacDonald‐Wicks · 2020 · BMC Health Services Research
  4. Reversibility of Psychotropic Medication Induced Weight Gain Among Children and Adolescents With Bipolar Disorders
    Upadhyay, Navneet, Patel, Ayush, Chan, Wenyaw, Aparasu, Rajender R., Ochoa-Perez, Melissa, Sherer, Jeff T., Sanyal, Swarnava, Chen, Hua · 2019 · Psychiatry Research
  5. Identifying determinants of diabetes risk and outcomes for people with severe mental illness: a mixed-methods study
    Jennie Lister, Lu Han, Sue Bellass, Jo Taylor, Sarah Louise Alderson, Tim Doran, Simon M. Gilbody, Catherine Elizabeth Hewitt, Richard I. G. Holt, Rowena Jacobs et al. · 2021 · Health Services and Delivery Research
  6. Homeless women with schizophrenia reported lower adherence to their medication than men: results from the French Housing First experience
    French Housing First Study Group, Aurélie Tinland, K. Zemmour, Pascal Auquier, Mohamed Boucékine, Vincent Girard, Sandrine Loubière, Guillaume B. Fond, Laurent Boyer · 2017 · Social Psychiatry and Psychiatric Epidemiology
  7. Nutritional Impact and Eating Pattern Changes in Schizophrenic Spectrum Disorders after Health Education Program on Symbiotic Dietary Modulation Offered by Specialised Psychiatric Nursing–Two-Arm Randomised Clinical Trial
    Alfonso Sevillano-Jiménez, Manuel Romero‐Saldaña, María García-Rodríguez, Rafael Molina‐Luque, Guillermo Molina‐Recio · 2022 · Nutrients
  8. Second generation antipsychotic-induced weight gain in youth with autism spectrum disorders: a brief review of mechanisms, monitoring practices, and indicated treatments
    Jeffrey Samuel Goltz, Iliyan Ivanov, Timothy Rice · 2019 · International Journal of Developmental Disabilities
  9. The “Double Whammy”: Women's Experiences of Weight Gain After Diagnosis and Treatment for Schizophrenia Spectrum Disorders
    Kirsti Haracz, Michael Hazelton, Carole L James · 2018 · The Journal of Nervous and Mental Disease
  10. Dietary Consumption Among Youth with Antipsychotic-Induced Weight Gain and Changes Following Healthy Lifestyle Education
    Kristin Bussell, Gloria M. Reeves, Erin R. Hager, Shijun Zhu, Christoph Ulrich Correll, Mark A. Riddle, Linmarie Sikich · 2021 · Journal of Child and Adolescent Psychopharmacology
  11. Psychiatric aspects of diabetes mellitus
    Anne Marie Doherty · 2015 · BJPsych Advances
  12. Obesity in Schizophrenia
    Seeman, Mary V. · 2016 · Journal of Obesity Management
  13. Cardiovascular Disease and Severe Mental Illness
    Richard I. G. Holt · 2014 · Key issues in mental health (Online)/Key issues in mental health (Print)
  14. Role of Integrated and Multidisciplinary Approach in Combating Metabolic Syndrome in Patients with Severe Mental Illness
    Pooja Patnaik Kuppili, Naresh Nebhinani · 2019 · Indian Journal of Psychological Medicine
  15. Strategies for prevention and management of second generation antipsychotic-induced metabolic side effects
    Marketa Marvanova · 2013 · Mental Health Clinician
  16. Safety and Effect of Bariatric Metabolic Surgeries for Psychiatric Patients with Obesity: A Retrospective Matched Case–control Trial
    Mohamed Hany, Mohamed Fahmy Aboudeeb, Clara Shapiro-Koss, Ann Samy Shafiq Agayby, Bart Torensma · 2023 · Obesity Surgery
  17. Die Effekte nicht-pharmakologischer, gesundheitsfördernder Interventionen bei Menschen mit schweren psychischen Erkrankungen
    Daniel Richter, Uta Gühne, Janine Stein, Stefan Weinmann, Thomas M Becker, Steffi Gerlinde Riedel-Heller · 2018 · Psychiatrische Praxis
  18. Self-Reported Health, Health Behaviors, Attitudes, and Beliefs of Regional Mental Health Consumers
    Brenda Happell, David S. Scott, Wendy Hoey, Robert Stanton · 2013 · Perspectives In Psychiatric Care
  19. Predictive Utility of Body Mass Index for Metabolic Syndrome Among Patients with Schizophrenia in Japan
    Norio Sugawara, Norio Yasui‐Furukori, Manabu Yamazaki, Kazutaka Shimoda, Takao Mori, Takuro Sugai, Hiroshi Matsuda, Yutaro Suzuki, Yuji Ozeki, Kurefu Okamoto et al. · 2020 · Neuropsychiatric Disease and Treatment
  20. Schizophrenia and Related Psychoses
    2021 · Wiley eBooks
  21. Nurse-led lifestyle intervention in a cohort of schizophrenia patients treated with clozapine
    Andrea Mallorquí, Cristina Oliveira, José Ríos, Maria Pilar Isla-Pera, Joaquín Gil-Badenes, Sílvia Amoretti, Miquel Bernardo, Eduard Vieta, Eduard Parellada, Marina Garriga et al. · 2023 · Archives of Psychiatric Nursing
  22. Integrated Review of Lifestyle Interventions Targeting Diet and Exercise in Early or First-Episode Psychosis
    Chris Griffiths, Farah Hina · 2021 · Open Journal of Psychiatry
  23. Twelve-month outcomes in overweight/obese users with mental disorders following a multi-element treatment including diet, physical activity, and positive thinking: the real-world "an apple a day" controlled trial
    Giusti, Laura, Bianchini, Valeria, Aggio, Annalisa, Mammarella, Silvia, Salza, Anna, Necozione, Stefano, Alunno, Alessia, Ferri, Claudio, Casacchia, Massimo, Roncone, Rita · 2022 · Frontiers in Psychiatry
  24. Weight gain under antipsychotic and mood stabilizing treatment: a narrative review about mechanisms and future options
    Hilda T. Seiter, Frederike T. Fellendorf, Darja Popkova, Eva Z. Reininghaus · 2025 · International Journal of Bipolar Disorders
  25. Pharmacological interventions for reducing weight gain in schizophrenia
    Margaret Hahn, Gary J. Remington, Markus J. Duncan, Tony A. Cohn, Guy Faulkner · 2014 · Cochrane Database of Systematic Reviews
  26. Characterizing the affective responses to an acute bout of moderate-intensity exercise among outpatients with schizophrenia
    Markus J. Duncan, Guy Faulkner, Gary J. Remington, Kelly P. Arbour‐Nicitopoulos · 2016 · Psychiatry Research
  27. METFORMIN IN THE PREVENTION OF METABOLIC SYNDROME ASSOCIATED WITH INITIATION OF ATYPICAL ANTIPSYCHOTIC THERAPY IN ADOLESCENTS AND YOUNG ADULTS - A RANDOMIZED, OPEN LABELLED, SINGLE CENTERED STUDY
    R. Vishnupriya, J. Ezhilramya, B. Meenakshi · 2016 · International Journal of Pharmacy and Pharmaceutical Sciences
  28. Psychiatric Rehabilitation
    Arundati Nagendra, Kim T. Mueser, Corinne Cather · 2022 · Springer eBooks
  29. Comparative efficacy of lifestyle intervention strategies on weight outcomes in people with psychosis: a systematic review and network meta-analysis protocol
    Doreen Mucheru, Mary‐Claire Hanlon, Mark McEvoy, Lesley K. MacDonald‐Wicks · 2017 · The JBI Database of Systematic Reviews and Implementation Reports
  30. Is there a therapeutic potential in combining bupropion and naltrexone in schizophrenia?
    Samer El Hayek, Malek Shatila, Jana A. Adnan, Luna Geagea, Firas H. Kobeissy, Farid Ramzi Talih · 2022 · Expert Review of Neurotherapeutics
  31. Effect of a 30-Month Health-Promoting Program on the Prevalence of Cardiovascular Risk Factors in Patients With First Episode Schizophrenia
    Hans Jørgen Søgaard, Mikkel Højlund, Anja Friis Elliott, Anne Grethe Viuff, Kirsten Vandborg, Jakob Hansen Viuff, Povl Munk‐Jørgensen, Peter Hjorth · 2018 · American Journal of Therapeutics
  32. Effectiveness of Short-Term Lifestyle Modification on Reducing Body- Weight-Related Parameters in Persons with Severe Mental Illness: A Randomized Controlled Trial
    Vinit Kumar Singh, Daliboina Muralidhar, Palash Kumar Malo, Binukumar Bhaskarapillai, Kesavan Muralidharan · 2023 · Indian Journal of Psychological Medicine
  33. Behavioural interventions for reducing weight gain in schizophrenia
    Guy Faulkner, Markus J. Duncan, Margaret Hahn, Gary J. Remington, Tony A. Cohn · 2013 · Cochrane Database of Systematic Reviews
  34. Effects of Transcranial Direct Current Stimulation (tDCS) and Approach Bias Modification (ABM) training on food cravings in people taking antipsychotic medication
    Luiza Grycuk, Gemma Gordon, Fiona Gaughran, Iain C. Campbell, Ulrike H Schmidt · 2020 · Trials
  35. Effects of Long-Term Multimodal Psychosocial Treatment on Antipsychotic-Induced Metabolic Changes in Patients With First Episode Psychosis
    Martina Rojnić Kuzman, Dina Bošnjak Kuharić, Ivana Kekin, Porin Makarić, Zoran Madžarac, Ana Koricancic Makar, Suzan Kudlek Mikulić, Žarko Bajić, Petra Bistrović, Dora Bonacin et al. · 2018 · Frontiers in Psychiatry
  36. Psychiatric Disorders and Diabetes
    Richard I. G. Holt, Leslie Citrome · 2016
  37. Promoting weight loss in people with schizophrenia: what do we still need to learn before implementing lifestyle interventions?
    Peter A Coventry, Emily Jane Peckham, Jo Taylor · 2019 · The British Journal of Psychiatry
  38. Can metabolic side effects of antipsychotics be reversed by lifestyle changes?
    Alistair Bolger, Norma Verdolini, Mark A Agius · 2014 · PubMed
  39. Non-pharmacological interventions reduce antipsychotic-associated weight gain in outpatients
    Fiona Gaughran, John Lally · 2012 · Evidence-Based Mental Health
  40. Commentary: A Randomized, Double-Blind, Placebo-Controlled Trial of Metformin Treatment of Weight Gain Associated with Initiation of Atypical Antipsychotic Therapy in Children and Adolescents
    Jeffrey Samuel Goltz, Timothy Rice · 2017 · Frontiers in Psychiatry
  41. Clinical Characterisation of the Co-Occurrence of Mental and Physical Disorders
    Richard I. G. Holt · 2025 · Springer eBooks
  42. Video consultation and treatment in the community smoking cessation therapy success rates in patients with mental illness: a randomized controlled trial
    Didde Marie Kaasgaard, Mette Knudsgaard Sørensen, Rikke Bleeg Christiansen, Uffe Nymark Breum, Nestor Asiamah, Lone Bülow Toft Friis, Peter Hjorth · 2024 · Nordic Journal of Psychiatry
  43. An appraisal of methodology reporting in lifestyle interventions among people with psychosis: A systematic review
    Doreen Mucheru, Mary‐Claire Hanlon, Mark McEvoy, Lesley K. MacDonald‐Wicks · 2019 · Health Promotion Journal of Australia
  44. A qualitative evaluation of a telehealth healthy lifestyle intervention for people with serious mental illness
    Donal O’Keeffe, Mary Clarke · 2023 · Irish Journal of Psychological Medicine
  45. Diabetes in psychiatric disease
    Richard I. G. Holt · 2014 · Medicine
  46. Physical Health of People with Mental Illness
    Richard I. G. Holt, David Shiers, Robert Peveler · 2018 · Cambridge University Press eBooks
  47. Prevención y tratamiento de los efectos adversos agudos más frecuentes por el uso de antipsicóticos en pacientes adultos con diagnóstico de esquizofrenia
    Álvaro Enrique Arenas Borrero, Carlos Gómez–Restrepo, Adriana Patricia Bohórquez Peñaranda, Ángela Vélez Traslaviña, Sergio Castro, Luis Eduardo Jaramillo González, Jenny García Valencia · 2014 · Revista Colombiana de Psiquiatría
  48. Therapeutic management of obesity induced by antipsychotic drugs
    Wojciech Merk, Michał Lew‐Starowicz · 2021 · Wiedza Medyczna
  49. Comparison of the Safety and Weight Loss Efficacy of Metformin and Liraglutide in Psychiatric Outpatients at a University Hospital: A Retrospective Chart Review
    Mansuk Seo, Won-Seok Choi, Young Sup Woo, Won‐Myong Bahk · 2024 · Mood and Emotion
  50. Psychopathological and cardiometabolic efficacy of a nutritional education intervention based on symbiotics in schizophrenia spectrum disorders. Two-arm Randomised Clinical Trial
    Alfonso Sevillano-Jiménez, Guillermo Molina‐Recio, Juan Antonio García-Mellado, Rafael Molina‐Luque, Manuel Romero‐Saldaña · 2024 · The European Journal of Psychiatry
  51. Non‐pharmacologicaL InterVEntions for Antipsychotic‐Induced Weight Gain (RESOLVE) in People Living With Severe Mental Illness: A Realist Synthesis
    Maura MacPhee, Jo Howe, Hafsah Habib, Emilia Piwowarczyk, Geoff Wong, Amy L. Ahern, Gurkiran K. Birdi, Suzanne Higgs, Sheri Oduola, Alex Kenny et al. · 2025 · Obesity Reviews
  52. Effects of Empagliflozin and Lifestyle Intervention on Improving Body Weight and Other Metabolic Parameters in Atypical Antipsychotics-treated Patients with Schizophrenia Spectrum Disorders—A Double-blind Randomized Placebo-controlled Trial
    Sin-ying Wong, SKC Chan, Yi-Man Flora Mo, Joshua Tsoh, Wing-Ho Oscar Wong, Tsun-Ming Yu, Sau-Man Sandra Chan, Hei-Ming Lai · 2026 · Schizophrenia Bulletin
  53. Management of Antipsychotic-Induced Weight Gain
    Jeffrey T. Rado · 2013 · Psychopharm Review
  54. Stakeholders' views about nutrition education
    Nicola Clibbens, Kevin Williamson · 2016 · British Journal of Mental Health Nursing
  55. Behavioural Interventions for Weight Management Among Patients with Schizophrenia
    M. Duncan, K. Davison, G. Remington, G. Faulkner · 2017 · Springer eBooks
  56. Aspetti psichiatrici del diabete mellito [translation of “Psychiatric aspects of diabetes mellitus” by Mattia Marchi]
    Anne Marie Doherty · 2015 · BJPsych Advances
  57. Management of Antipsychotic-Induced Weight Gain
    Jeffrey T. Rado, Kathryn Sarah Keim, Sheila M. Dowd · 2013 · Psychopharm Review
  58. Time-Restricted Feeding May Be a New Intervention to Improve Metabolism of Schizophrenia Patients
    雪倩 马 · 2021 · International Journal of Psychiatry and Neurology
  59. Part II : Interactive case—Clinical pearls of clozapine
    Jonathan G. Leung · 2023 · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY
  60. Schizophrenia and Related Psychoses
    2025 · Wiley eBooks
  61. Management of Comorbid Medical Conditions in Schizophrenia
    Jeffrey T. Rado · 2014 · Springer eBooks
  62. Kartlegging av kardiovaskulær risiko i en akutt psykoseenhet og videreføring av informasjon til DPS
    Naema Noor, Elma Bahonjic, Ingvild Karlsen Eeg, Hans Kristian Fløystad, Åsmund Treu Røe, Heidi Selnes, Berit Volden Snekvik · 2015 · NORA - Norwegian Open Research Archives
  63. Effective primary care for individuals with serious mental illness: an intervention and systematic review
    Cynthia H Nover · 2015 · J. Willard Marriott Library
  64. Characterizing the Affective Responses to an Acute Bout of Moderate-intensity Exercise in People with Schizophrenia
    Markus J. Duncan · 2014 · TSpace (University of Toronto)
  65. The Totara House Healthy Eating Study: A qualitative investigation into the feasibility of adapting the Senior Chef programme for patients in a mental health setting.
    Aimee Borich · 2017 · Otago University Research Archive (University of Otago)
  66. Prevention and Treatment of Obesity and Metabolic Dysfunction in Children with Major Behavioral Disorders: Second-Generation Antipsychotics
    Gloria M. Reeves, Linmarie Sikich · 2017 · Contemporary Endocrinology
  67. Review Obesity and Serious Mental Ill Health: A Critical Review of the Literature
    Tim Bradshaw, Hilary Mairs · 2014
  68. Effectiveness of interventions to support weight loss in adults taking antipsychotics: a review
    Deborah Ayodele, Jennifer Oates · 2019 · British Journal of Mental Health Nursing
  69. Health risk factors associated with morbidity and mortality in a national sample of people with psychosis
    Lisa Anne Hahn · 2017 · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
  70. What is the treatment for adults taking antipsychotics who develop weight gain?
    Dana L. Brandenburg, Deirdre Paulson · 2019 · Evidence-Based Practice
  71. Antipsychotics, Weight Gain and Metabolic Risk
    Stephen J Cooper, Gavin P. Reynolds · 2020 · Cambridge University Press eBooks
  72. Empfohlene psychosoziale Therapien bei schweren psychischen Erkrankungen
    Uta Gühne, Stefan Weinmann, Thomas M Becker, Steffi Gerlinde Riedel-Heller · 2020 · InFo Neurologie + Psychiatrie
  73. Psychosoziale Therapien bei schwer psychisch kranken Menschen
    Uta Gühne, Steffi Gerlinde Riedel-Heller · 2021 · NeuroTransmitter
  74. Le défi de l’obésité dans les maladies psychiatriques
    Sébastien Guillaume, Patrick Ritz · 2023 · Nutrition Clinique et Métabolisme
  75. Mental Disorders and Diabetes
    Najma Siddiqi, Marietta Stadler, Richard I. G. Holt · 2024 · Wiley eBooks
  76. REalist Synthesis Of non-pharmacologicaL interVEntions for antipsychotic-induced weight gain (RESOLVE) in people living with severe mental illness
    Maura MacPhee, Jo Howe, Hafsah Habib, Emilia Piwowarczyk, Geoff Wong, Amy L. Ahern, Gurkiran K. Birdi, Suzanne Higgs, Sheri Oduola, Alex Kenny et al. · 2024 · medRxiv
  77. Diabetes Mellitus and Psychiatric Disorders
    Anju Kuruvilla · 2024 · Springer eBooks
  78. Practical approaches to cardiac clearance in nontraditional clinical scenarios
    Ethan F. Kramer, J.F. Ricci, Krunal Shukla, Noah J. Blaker, Sajan Shroff, Stephen J Brand, Tawfiq Khasawneh, Shruti Sreekanth, David E. Winchester · 2025 · The American Journal of Medicine
  79. Exploring the challenges of managing diabetes mellitus in an in-patient psychiatric setting
    Elegia Clancey, Parveen Dhesi, Prachi Patel, Ioanna Zimianiti, M. Biswas · 2025 · BJPsych Advances
  80. The effect of switching antipsychotics to aripiprazole versus paliperidone on weight/cardiometabolic parameters: 18-month follow-up findings from the European Long-acting Antipsychotics in Schizophrenia Trial (EULAST)
    Nini de Boer, Zara Vučko, Derek IJsbrand Koster, Marte Z. van der Horst, Michael Davidson, Wiepke Cahn, Jurjen Justin Luykx · 2025 · European Neuropsychopharmacology
  81. Additional file 1 of Factors to consider during the implementation of nutrition and physical activity trials for people with psychotic illness into an Australian community setting
    Doreen Mucheru, Samantha Ashby, Hanlon, Mary-Claire, Mark McEvoy, Lesley K. MacDonald‐Wicks · 2020 · Figshare
  82. Additional file 1 of Impact of high prebiotic and probiotic dietary education in the SARS-CoV-2 era: improved cardio-metabolic profile in schizophrenia spectrum disorders
    Alfonso Sevillano-Jiménez, Manuel Romero‐Saldaña, Juan Antonio García-Mellado, Lorena Carrascal-Laso, García-Rodríguez, María, Rafael Molina‐Luque, Guillermo Molina‐Recio · 2024 · Figshare